Fermata Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Fermata Advisors's ABBV Position: Q3 2026 in Review
Fermata Advisors increased its AbbVie (ABBV) stake by 24% in Q3 2026, buying an estimated $55.1K and bringing the position to 1,124 shares worth $294K. The position accounts for 0.06% of the portfolio, ranked #212.
Fermata Advisors first reported a position in ABBV in Q2 2021 and has held it in 14 quarters since. The position peaked at $414K in Q1 2022. 1,321 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Fermata Advisors held 1,124 shares of AbbVie worth $294K as of Q3 2026.
- Fermata Advisors bought 215 AbbVie shares in Q3 2026, an estimated $55.1K.
- AbbVie made up 0.06% of Fermata Advisors's portfolio in Q3 2026, its #212 holding.
- Fermata Advisors first reported a position in AbbVie in Q2 2021 and has held it in 14 quarters since.
- Fermata Advisors's AbbVie position peaked at $414K in Q1 2022.
- 1,321 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Fermata Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.